Peanut skin polyphenols inhibit proliferation of leukemia cells in vitro, and its A‐type procyanidins selectively pass through a Caco‐2 intestinal barrier

Increased consumption of nuts is associated with reduced risk of some forms of cancer, including leukemia. Peanut skins are not typically retained during food processing but are a potential source of anticarcinogenic polyphenols. There are limited data about the antileukemic activity and bioavailability of peanut skin polyphenols. This study determined the polyphenol profile of raw peanut skin extract (PSE), its antiproliferative activity toward Jurkat cells, and intestinal bioavailability and metabolism using a Caco-2 intestinal monolayer model. High-resolution mass spectrometry (UHPLC-Q-Orbitrap) was used to analyze PSE and extracts of PSE-treated Jurkat cells to determine PSE polyphenols associated with antiproliferative activity. PSE reduced Jurkat cell viability, indicating its antiproliferative activity. PSE contained at least 63 polyphenols, including phenolic acids, proanthocyanidins, and prenylated flavonoids, among others. Multiple PSE polyphenols, particularly proanthocyanidins with A-type bonds, interacted with Jurkat cells. In Caco-2 cells, PSE intestinal bioavailability was limited to (+)-catechin, quercetin, procyanidin A2, and tentatively procyanidin A1. Caco-2 cells metabolized PSE polyphenols, including the methylation of A-type procyanidin dimer. Thus, these cell-based studies demonstrate that raw peanut skins contain intestinal bioavailable polyphenols with potential antileukemic properties. PSE polyphenols, including A-type proanthocyanidins, were metabolized by intestinal cells. Thus, the antileukemic activity of PSE polyphenols is modulated by the bioavailability and metabolism of A-type proanthocyanidins. PRACTICAL APPLICATION: Raw peanut skins are rich in polyphenols, including A-type proanthocyanidins. Extracts of peanut skins inhibit the growth of cultured leukemia cells, and peanut A-type proanthocyanidins are associated with this effect. Peanut skins are not typically retained in food processing, so further research and development are needed to recover or retain these compounds and document their health-promoting activities in human research studies.

Authors

Institutions

Publication Details

Journal
Journal of Food Science
Published
2025-02-01
DOI
https://doi.org/10.1111/1750-3841.70018
Citations
3
Primary Topic
Phytochemicals and Antioxidant Activities
Type
article
Field-Weighted Citation Impact
2.32
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Peanut skin polyphenols inhibit proliferation of leukemia cells in vitro, and its A‐type procyanidins selectively pass through a Caco‐2 intestinal barrier

Chandra K. Singh, Nihal Ahmad, Yaa Asantewaa Kafui Klu, Bradley W. Bolling et al.
3 citations
Journal of Food Science
Phytochemicals and Antioxidant Activities
2.32
article

Peanut skin polyphenols inhibit proliferation of leukemia cells in vitro, and its A‐type procyanidins selectively pass through a Caco‐2 intestinal barrier

Chandra K. Singh, Nihal Ahmad, Yaa Asantewaa Kafui Klu, Bradley W. Bolling, Pornpat Jantip
article en
3 citations

Abstract

Increased consumption of nuts is associated with reduced risk of some forms of cancer, including leukemia. Peanut skins are not typically retained during food processing but are a potential source of anticarcinogenic polyphenols. There are limited data about the antileukemic activity and bioavailability of peanut skin polyphenols. This study determined the polyphenol profile of raw peanut skin extract (PSE), its antiproliferative activity toward Jurkat cells, and intestinal bioavailability and metabolism using a Caco-2 intestinal monolayer model. High-resolution mass spectrometry (UHPLC-Q-Orbitrap) was used to analyze PSE and extracts of PSE-treated Jurkat cells to determine PSE polyphenols associated with antiproliferative activity. PSE reduced Jurkat cell viability, indicating its antiproliferative activity. PSE contained at least 63 polyphenols, including phenolic acids, proanthocyanidins, and prenylated flavonoids, among others. Multiple PSE polyphenols, particularly proanthocyanidins with A-type bonds, interacted with Jurkat cells. In Caco-2 cells, PSE intestinal bioavailability was limited to (+)-catechin, quercetin, procyanidin A2, and tentatively procyanidin A1. Caco-2 cells metabolized PSE polyphenols, including the methylation of A-type procyanidin dimer. Thus, these cell-based studies demonstrate that raw peanut skins contain intestinal bioavailable polyphenols with potential antileukemic properties. PSE polyphenols, including A-type proanthocyanidins, were metabolized by intestinal cells. Thus, the antileukemic activity of PSE polyphenols is modulated by the bioavailability and metabolism of A-type proanthocyanidins. PRACTICAL APPLICATION: Raw peanut skins are rich in polyphenols, including A-type proanthocyanidins. Extracts of peanut skins inhibit the growth of cultured leukemia cells, and peanut A-type proanthocyanidins are associated with this effect. Peanut skins are not typically retained in food processing, so further research and development are needed to recover or retain these compounds and document their health-promoting activities in human research studies.

Journal of Food ScienceVol. 90(2)
University of Wisconsin–Madison (US)
Zero hunger
Openalex Percentile: Top 13%
Phytochemicals and Antioxidant Activities
2.32
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.